Literature DB >> 17375526

FGFR3 mutation in thanatophoric dysplasia type 1 with bilateral cystic renal dysplasia: coincidence or a new association?

P Prontera1, A Sensi, G Pilu, M Baldi, M Baffico, R Bonasoni, E Calzolari.   

Abstract

Thanatophoric dysplasia (TD) is a lethal dwarfism condition due to missense mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. Examination of TD patients reveals mainly the involvement of the skeletal system and the brain, but also renal and cardiovascular anomalies have been described. We report the prenatal detection of TD type 1 (TD1) associated with bilateral cystic renal dysplasia (CRD) Potter's type II, in which the molecular analysis reveals the typical Arg248Cys substitution in the FGFR3 gene. CRD has not been previously described in TD or other conditions due to FGFR3 mutations, but occurs in Apert syndrome (due to FGFR2 mutations). The possible involvement of renal developmental defect in FGFR3 mutations is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17375526

Source DB:  PubMed          Journal:  Genet Couns        ISSN: 1015-8146


  6 in total

Review 1.  Role of fibroblast growth factor receptor signaling in kidney development.

Authors:  Carlton M Bates
Journal:  Pediatr Nephrol       Date:  2011-01-11       Impact factor: 3.714

Review 2.  Fibroblast growth factor receptor signaling in kidney and lower urinary tract development.

Authors:  Kenneth A Walker; Sunder Sims-Lucas; Carlton M Bates
Journal:  Pediatr Nephrol       Date:  2015-08-21       Impact factor: 3.714

Review 3.  Role of fibroblast growth factor receptor signaling in kidney development.

Authors:  Carlton M Bates
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-25

4.  Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma.

Authors:  C G Stoehr; R Stoehr; A Hartmann; F Hofstaedter; K Junker; H Blaszyk; W F Wieland; W Otto; S Denzinger; B Walter
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-28       Impact factor: 4.553

5.  Unique phenotype in a patient with CHARGE syndrome.

Authors:  Shobhit Jain; Hyung-Goo Kim; Felicitas Lacbawan; Irene Meliciani; Wolfgang Wenzel; Ingo Kurth; Josefina Sharma; Morris Schoeneman; Svetlana Ten; Lawrence C Layman; Elka Jacobson-Dickman
Journal:  Int J Pediatr Endocrinol       Date:  2011-10-13

6.  DNA copy number variations in children with vesicoureteral reflux and urinary tract infections.

Authors:  Dong Liang; Kirk M McHugh; Pat D Brophy; Nader Shaikh; J Robert Manak; Peter Andrews; Inessa Hakker; Zihua Wang; Andrew L Schwaderer; David S Hains
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.